Stockreport

Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market [Globe and Mail, The (Toronto, Canada)]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF NEW YORK Feb. 10, 2026 /CNW/ -- Novel serotonergic agonists ("NSAs") are quickly becoming one of the more interesting stories in mental-health and neuroscience investin [Read more]